• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 488082 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414792304 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414792304 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Buyers Accumulating Shares of Amarin on 1.6x Above-Average Volume (AMRN)

Published on Fri, 04/26/2013 - 13:16
By Peter Chu

Amarin shares are trading on heavy volume today, having risen 5.9% to $6.77. Approximately 5.4 million shares have changed hands today vs. average 30-day volume of 3.4 million shares. Unusually high volume can signify a potential turning point or validate a breakout.

In the past 52 weeks, shares of Amarin have traded between a low of $6.34 and a high of $15.96 and are now at $6.77, which is 7% above that low price. The 200-day and 50-day moving averages have moved 1.22% lower and 1.41% lower over the past week, respectively.

Amarin (NASDAQ:AMRN) has potential upside of 125.8% based on a current price of $6.77 and analysts' consensus price target of $15.29. The stock should find initial resistance at its 50-day moving average (MA) of $7.78 and further resistance at its 200-day MA of $10.48.

Amarin Corporation PLC is a clinical-stage biopharmaceutical company. The Company researches, develops, and commercializes drugs for the treatment of hypertriglyceridemia, central nervous system disorders, and cardiovascular diseases.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Recent 52-Week High Exceeded in Shares o...

SCANA (NYSE:SCG) traded today at a new 52-week high of $55.05. This new high was reach ...

Shares of SBA Communications Have Risen ...

Shares of SBA Communications (NASDAQ:SBAC) traded today at $116.05, breaking its 52-wee ...

Shares of Sanmina-SCI Rise to a New 52-W...

Sanmina-SCI (NASDAQ:SANM) traded today at a new 52-week high of $25.25. So far today a ...

Shares of Seabridge Gold Fall Below Prev...

Shares of Seabridge Gold (AMEX:SA) traded today at $6.21, breaking its 52-week low. Th ...

Shares of Raytheon Rise Above Previous 5...

Raytheon (NYSE:RTN) traded today at a new 52-week high of $104.97. So far today approx ...

Ramco-Gershenson Properties Trust Looks ...

Ramco-Gershenson Properties Trust (NYSE:RPT) traded at a new 52-week high today of $17. ...

Ross Stores Looks to Continue to Trade A...

Shares of Ross Stores (NASDAQ:ROST) traded today at $82.00, breaking its 52-week high. ...

Roper Industries: 52-Week High Recently ...

Roper Industries (NYSE:ROP) traded at a new 52-week high today of $159.19. Approximate ...